Top-News
Biotechnologie Schweden

BIOVICA INTERNATIONAL Aktie

Aktie
WKN:  A2DPS4 ISIN:  SE0008613731
0,1796 €
-0,0259 €
-12,60%
13.12.24
Handeln Depot/Watchlist
Aktienanzahl *
-
Marktkapitalisierung *
-
Streubesitz
-
Index-Zugehörigkeit
-

BIOVICA INTERNATIONAL News

25.09.20 - PR Newswire
Biovica completes 510(k) submission for DiviTum®TKa to the FDA
Biovica completes 510(k) submission for DiviTum®TKa to the FDA PR Newswire
16.01.20 - PR Newswire
Clinical Cancer Research Publishes Results Supporting DiviTum as a Technology for Early Evaluation of Metastatic Breast Cancer Treatment
Clinical Cancer Research Publishes Results Supporting DiviTum as a Technology for Early Evaluation of Metastatic Breast Cancer Treatment PR Newswire
06.12.19 - PR Newswire
Biovica Strengthens Management Team
Biovica Strengthens Management Team PR Newswire
20.11.19 - PR Newswire
Biovica's DiviTum Validated as a Dynamic Biomarker in Metastatic Breast Cancer in Collaboration With Institut Curie, Paris
Biovica's DiviTum Validated as a Dynamic Biomarker in Metastatic Breast Cancer in Collaboration With Institut Curie, Paris PR Newswire
18.09.19 - PR Newswire
DiviTum® Included in New U.S. Cancer Study
DiviTum® Included in New U.S. Cancer Study PR Newswire
22.05.19 - PR Newswire
Biovica Publishes a Summary of Study-results in Breast Cancer With DiviTum®
Biovica Publishes a Summary of Study-​results in Breast Cancer With DiviTum® PR Newswire
06.05.19 - PR Newswire
Biovica: Positive DiviTum® Study Results Published in Highly-renowned European Journal of Cancer
Biovica: Positive DiviTum® Study Results Published in Highly-​renowned European Journal of Cancer The strong results from the previously presented EFECT study have now been ...
10.04.19 - PR Newswire
Biovica and IBL America has Agreed on a Sales Collaboration for the US Market
Biovica and IBL America has Agreed on a Sales Collaboration for the US Market PR Newswire
04.12.18 - PR Newswire
Biovica Establishes Office in Boston
Biovica Establishes Office in Boston PR Newswire
28.09.18 - PR Newswire
Lars Holmqvist to Biovica as Senior Advisor
Lars Holmqvist to Biovica as Senior Advisor PR Newswire
04.06.18 - PR Newswire
Results From AstraZeneca Study Presented Today at ASCO
Results From AstraZeneca Study Presented Today at ASCO PR Newswire
17.05.18 - PR Newswire
New Study Results Presented at ASCO Supports DiviTum® for Monitoring Advanced Breast Cancer Treatment - Biovica International AB
New Study Results Presented at ASCO Supports DiviTum® for Monitoring Advanced Breast Cancer Treatment - Biovica International AB PR Newswire
17.04.18 - PR Newswire
Biovica International - Positive Results With DiviTum® From New Pfizer Study Presented at the AACR Congress
Biovica International - Positive Results With DiviTum® From New Pfizer Study Presented at the AACR Congress PR Newswire
28.03.18 - PR Newswire
Biovica International AB: New Positive Results Support Early Treatment Evaluation of Breast Cancer Using DiviTum
Biovica International AB: New Positive Results Support Early Treatment Evaluation of Breast Cancer Using DiviTum PR Newswire

Newssuche

Videos

newspaper
13.12.24
TRADING Insights Webinar vom 12.12.24
Themen: Aktienmarkt-​Entwicklung, Soft-​Commodities, wie Baumwolle, Kakao, Orangensaft, aber auch die ... Mehr »